핵산 샘플 전처리 소모품 시장 - 세계 및 지역별 분석 : 워크플로우별, 유래별, 기술별, 다운스트림 용도별, 최종사용자별 및 국가별 - 분석과 예측(2025-2035년)

This report can be delivered within 1 working day.

Introduction of the Nucleic Acid Sample Preparation Consumables Market

The global nucleic acid sample preparation consumables market, initially valued at $1,726.2 million in 2024, is projected to witness substantial growth, surging to $2,816.8 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 4.37% over the period from 2025 to 2035.

The global nucleic acid sample preparation consumables market is witnessing robust growth, driven by the increasing demand for high-throughput, accurate, and scalable molecular workflows amid rising testing volumes and expanding applications in diagnostics and research. Nucleic acid sample preparation has become a critical upstream step across healthcare and life sciences, particularly in molecular diagnostics, infectious disease testing, oncology, and genomics research, where high-quality DNA and RNA extraction is essential for reliable downstream analysis. The growing prevalence of infectious diseases and cancer, along with the rising number of genetic tests and microbial sequencing applications, is further strengthening the role of sample preparation consumables across clinical laboratories, research institutes, and diagnostic settings. The integration of automation into sample preparation workflows is transforming conventional laboratory processes by enabling standardized extraction, reducing manual variability, and improving turnaround times. These consumables are particularly critical in high-volume environments such as clinical diagnostics and research laboratories, where consistency, scalability, and accuracy are essential. As healthcare and research systems shift toward precision medicine and operational efficiency, the adoption of advanced and automation-compatible consumables is accelerating to enhance reproducibility, optimize workflows, and support large-scale testing demands.

Technological advancements in reagent chemistry, magnetic particle-based technologies, and automation-compatible consumables are significantly enhancing sample preparation capabilities. Innovations focused on improving nucleic acid yield, purity, and consistency are enabling better performance in downstream applications such as qPCR and next-generation sequencing (NGS). In addition, the increasing integration of consumables with automated extraction platforms and standardized laboratory workflows is enabling scalable deployment across multi-site laboratories and supporting efficient, high-throughput operations. The growing emphasis on workflow standardization and interoperability across laboratory systems is further driving the transition from manual, fragmented processes to integrated, automation-driven sample preparation solutions. However, the market continues to face challenges, including high costs of consumables, stringent regulatory and quality compliance requirements, and the need for standardized workflows across diverse laboratory environments. Despite these challenges, increasing investments in genomics research, expansion of diagnostic infrastructure, and strategic collaborations among life sciences companies, research institutions, and healthcare providers are expected to drive sustained growth and innovation in the nucleic acid sample preparation consumables market.

Market Introduction

The global nucleic acid sample preparation consumables market has undergone a notable transformation, driven by continuous technological advancements and increasing integration of automation into laboratory workflows. Companies are progressively developing automation-compatible, ready-to-use consumables to enhance extraction efficiency, improve reproducibility, and reduce hands-on time in laboratory settings. These innovations support a wide range of applications, including molecular diagnostics, genomics, infectious disease testing, and precision medicine, enabling faster, more accurate, and standardized outcomes.

Key advancements, such as magnetic bead-based extraction technologies, high-efficiency reagent chemistries, and automation-ready kits, highlight the industry's focus on improving sample quality, minimizing contamination risks, and increasing processing throughput. Additionally, the integration of sample preparation consumables with automated platforms and digital laboratory systems is enhancing workflow efficiency, data consistency, and operational scalability across laboratories.

The growing demand for molecular testing, increasing research activity in genomics, and rising focus on early disease detection are further accelerating adoption across both developed and emerging markets. As healthcare and research ecosystems continue to prioritize accuracy, scalability, and efficiency, ongoing innovations in nucleic acid sample preparation consumables are expected to play a critical role in shaping the future of molecular diagnostics and life sciences workflows.

Industrial Impact

The global nucleic acid sample preparation consumables market has witnessed substantial growth, driven by the increasing adoption of molecular diagnostics, the rising prevalence of infectious diseases and cancer, and the expanding use of genomic technologies such as next-generation sequencing (NGS) and PCR-based applications. Key players such as Thermo Fisher Scientific Inc., Danaher Corporation, QIAGEN N.V., F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Promega Corporation, and LGC Biosearch Technologies are playing a pivotal role in advancing sample preparation technologies through continuous innovation and strategic investments.

These companies are actively focusing on the development of automation-compatible consumables, high-efficiency extraction kits, and advanced reagent chemistries, which are transforming sample preparation workflows and enabling high-throughput, reproducible, and scalable operations across clinical and research settings. Such innovations are improving nucleic acid yield, purity, and consistency, thereby enhancing the reliability of downstream applications such as qPCR and NGS.

At the same time, increasing demand from emerging markets is encouraging manufacturers to develop cost-effective, standardized, and easy-to-use consumables tailored to resource-constrained laboratory environments, thereby expanding access to molecular diagnostics and genomics research. Strategic collaborations between consumable manufacturers, diagnostic laboratories, research institutions, and automation solution providers are further supporting innovation and market expansion.

Additionally, the integration of sample preparation consumables with automated platforms and standardized workflows is improving laboratory efficiency, reducing hands-on time, and minimizing variability, thereby supporting high-volume testing environments. Overall, nucleic acid sample preparation consumables are enhancing workflow reliability, enabling scalable molecular testing, and supporting broader advancements across the genomics, diagnostics, and life sciences ecosystems.

Market Segmentation:

Segmentation 1: By Source Type

• DNA
• RNA

DNA Segment to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Source Type)

In terms of source type, the DNA segment is expected to lead the nucleic acid sample preparation consumables market, driven by increasing demand for high-grade DNA, availability of diverse DNA extraction kits worldwide, and massively growing demand for nucleic acid, particularly DNA, for different downstream processes such as NGS, PCR, cloning, and restriction enzyme analysis.

Segmentation 2: By Workflow

• Sample Isolation/Extraction/Purification
• DNA/RNA Clean-Up and Concentration
• DNA/RNA Quantification

Sample Isolation/Extraction/Purification to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Workflow)

In terms of workflow, sample isolation/extraction/purification is expected to lead the nucleic acid sample preparation consumables market. These steps are highly consumable-intensive, involve multiple reagents and single-use components per sample, and scale directly with testing volumes.

Segmentation 3: By Technology

• Silica-Based Technology
• Magnetic Particle Technology
• Other Technologies

Magnetic Particle Technology to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Technology)

In terms of technology, magnetic particle technology is expected to lead the nucleic acid sample preparation consumables market as it offers high binding efficiency, consistent yields, and strong compatibility with automated and high-throughput workflows, making it the preferred choice in clinical diagnostics and large-scale testing environments. In addition, its scalability across sample types and reduced hands-on time drive repeat consumable usage and reinforce its dominance over silica-based and alternative technologies.

Segmentation 4: By Downstream Application

• PCR
• qPCR
• NGS
• Cloning
• Microarray
• Blotting Techniques
• Other Applications

qPCR to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Downstream Application)

In terms of downstream application, qPCR is expected to lead the nucleic acid sample preparation consumables market as it offers the most routinely used nucleic acid-based technique in clinical diagnostics, infectious disease testing, and routine laboratory workflows, driving consistently high sample volumes.

Segmentation 5: By End User

• Academic Research Institutes and Laboratories
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Clinical Diagnostic Centers
• Applied Testing

Academic Research Institutes and Laboratories to Dominate the Nucleic Acid Sample Preparation Consumables Market (by End User)

In terms of end user, academic research institutes and laboratories are expected to lead the global nucleic acid sample preparation consumables market, driven by the rising research in the field of molecular biology, the growing interest in studying the human genome, the growing demand for novel techniques to extract high-quality nucleic material, and the rise in funding for various downstream applications, such as NGS and PCR.

Segmentation 6: By Region

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Poland
  • Portugal
  • Russia
  • Rest-of-Europe
• Asia-Pacific
  • China
  • Japan
  • Australia
  • India
  • Malaysia
  • South Korea
  • Thailand
  • Taiwan
  • Singapore
  • Indonesia
  • Philippines
  • Rest-of-Asia-Pacific
• Latin America
  • Brazil
  • Argentina
  • Chile
  • Colombia
  • Mexico
  • Rest-of-Latin America
• Middle East and Africa
  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Rest-of-Middle East and Africa

North America to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Region)

North America is expected to lead the global nucleic acid sample preparation consumables market, due to the presence of prominent market players in the U.S. and the rising number of applications of extracted nucleic acid in research, diagnostics, and synthetic biology. The growing prevalence of infectious diseases, genetic disorders, and chronic diseases, and the development of novel sample extraction kits are some of the factors that also lead to the dominance of North America in the global nucleic acid sample preparation consumables market.

Recent Developments in the Nucleic Acid Sample Preparation Consumables Market

• In Oct 2025, AutoGen, Inc. partnered with Sampled to deliver next-generation nucleic acid extraction and multi-omic workflows. Under the agreement, Sampled refers complex extraction projects to AutoGen; AutoGen refers large-scale extraction and downstream analysis to Sampled's integrated laboratory services.
• In Oct 2025, LGC Biosearch Technologies, Inc. opened a new National Laboratories facility in Guildford to support broader R&D and service capabilities.
• In Sep 2025, Promega Corporation partnered with Watchmaker Genomics to license a next-generation engineered reverse transcriptase to enhance RNA analysis performance.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Growing Number of Genetic Tests: The rapid expansion in the number of genetic tests is a key structural driver for the nucleic acid sample preparation consumables market, as each test requires high-quality DNA or RNA extraction and purification prior to analysis. This growth reflects the transition of genetic testing from niche applications to routine use in clinical diagnostics, research, and personalized medicine. As most of these tests are clinically oriented, they generate consistent demand for consumables such as extraction kits, reagents, and buffers. Additionally, the expanding test menu across multiple disease areas is increasing the need for standardized, reliable, and regulatory-compliant sample preparation workflows, thereby reinforcing sustained and recurring demand for nucleic acid sample preparation consumables.

Market Restraints

Genomic Data Protection: Growing concerns around genomic data privacy, security, and ethical use are emerging as a key restraint for the nucleic acid sample preparation consumables market, particularly in workflows involving human genetic material. High-profile data breaches have exposed vulnerabilities in genomic data storage and handling, leading to increased regulatory scrutiny and financial penalties. These incidents have heightened consumer and institutional concerns regarding the misuse of sensitive genetic information, including health data, ancestry, and familial links. As a result, stricter data protection regulations and more cautious approaches toward large-scale genomic studies are being adopted in several regions. This growing hesitancy among individuals and institutions to participate in genetic testing, especially in less regulated environments, can limit testing volumes and, in turn, moderate the demand for nucleic acid extraction and purification consumables used in sample preparation workflows.

Market Opportunities

Development and Increased Utilization of Biobanks in the Healthcare Segment: The expanding development and utilization of biobanks represent a significant market opportunity for nucleic acid sample preparation consumables, driven by increasing investments from governments, research organizations, and philanthropic institutions. Large-scale biobanking initiatives across regions are accelerating biospecimen collection, enhancing long-term storage capabilities, and advancing research infrastructure. These developments are increasing demand for high-quality DNA and RNA extraction, stabilization, and purification consumables required for large-scale and long-duration genomic research. As biobanks continue to support population genomics, precision medicine, and longitudinal disease studies, they create recurring and sustained demand for standardized, automation-compatible, and high-performance sample preparation consumables, making this a strong and long-term growth opportunity in the market.

How can this report add value to an organization?

Product/Innovation Strategy: The global nucleic acid sample preparation consumables market has been divided into several key segments, including source type, workflow, technology, downstream application, end users, and regional markets. By understanding which segments hold the largest share and which ones show potential for growth, this report offers invaluable insights for organizations looking to innovate and expand their product offerings.

Growth/Marketing Strategy: Strategic partnerships, collaborations, and business expansions are anticipated to be central to the growth of the nucleic acid sample preparation consumables market. Key developments and partnerships among diagnostic companies, healthcare providers, and research institutions have already begun to form a significant part of the market dynamics.

Competitive Strategy: The nucleic acid sample preparation consumables market is highly competitive, with numerous well-established players offering nucleic acid sample preparation consumables. Key market participants are focusing on innovation in automation-compatible consumables, high-throughput sample processing, and standardized ready-to-use kits. Additionally, companies are emphasizing product differentiation through improved efficiency, compatibility with diverse sample types, and seamless integration with advanced molecular workflows such as PCR and next-generation sequencing.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• Years from 2024 to 2035 have been considered for the global market size estimation, 2024 has been considered as the base year, and 2025 to 2035 as the forecast period.
• The scope of the report is based on comprehensive inputs from industry experts across various sectors, including clinical and diagnostic laboratories, biotechnology and pharmaceutical companies, contract research organizations (CROs), academic and research institutes, and genomics service providers.
• The market contribution of nucleic acid sample preparation consumables is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
• Revenues from companies have been sourced from their annual reports for FY2023 and FY2024. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
• The market has been mapped based on the existing nucleic acid sample preparation consumables, including extraction kits, purification reagents, and workflow-compatible consumables. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts and key stakeholders across the life sciences and nucleic acid sample preparation consumables ecosystem, including consumable manufacturers, molecular diagnostics companies, and laboratory automation solution providers. Stakeholders such as clinical and diagnostic laboratories, biotechnology and pharmaceutical companies, academic and research institutes, and contract research organizations (CROs) have been consulted to validate adoption trends, workflow integration, and application-specific usage of sample preparation consumables. Respondents, including CEOs, vice presidents, product and marketing directors, laboratory managers, and genomics and molecular biology experts, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

• validation and triangulation of all the numbers and graphs
• validation of report segmentations and key qualitative findings
• understanding the competitive landscape and business model
• current and proposed production values of a product by market players
• validation of the numbers of different segments of the market in focus
• percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
• Annual reports, SEC filings, and investors' presentations of the leading market players
• Company websites and a detailed study of their product portfolio
• Gold standard magazines, journals, white papers, press releases, and news articles
• Paid databases

The key data points taken from the secondary sources include:

• segmentations and percentage shares
• data for market value
• key industry trends of the top players in the market
• qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Agilent Technologies, Inc.
• AutoGen Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Merck KGaA
• Macherey-Nagel GmbH & Co KG
• New England Biolabs
• Norgen Biotek Corp
• Omega Bio-tek, Inc.
• QIAGEN N.V.
• Revvity, Inc. (PerkinElmer, Inc.)
• Thermo Fisher Scientific Inc.
• Promega Corporation
• Zymo Research
• LGC Biosearch Technologies
• Danaher Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

• 1.1 Market Overview
• 1.2 Pricing Analysis
• 1.3 Market Attractiveness: Macro and Micro Factor Analysis
• 1.4 Regulatory Outlook
• 1.5 Key Trends
  • 1.5.1 Transition from Episodic Diagnostic Testing to Longitudinal and Repeat Molecular Testing Workflows
  • 1.5.2 Real-World Data Points and Industry Instances
  • 1.5.3 Increasing Fragmentation of Sample Types Driving Demand for Application-Specific Consumables
• 1.6 Market Dynamics
  • 1.6.1 Market Drivers
    • 1.6.1.1 Growing Number of Genetic Tests
    • 1.6.1.2 Increasing Prevalence of Infectious Diseases and Cancer Cases
    • 1.6.1.3 Rise in Microbial Sequencing
    • 1.6.1.4 Increasing Adoption of NGS-Based Testing in Clinical Laboratories
  • 1.6.2 Market Restraints
    • 1.6.2.1 Genomic Data Protection
    • 1.6.2.2 High Cost of Nucleic Acid Sample Preparation Consumables
    • 1.6.2.3 Stringent Regulatory and Quality Compliance Requirements
  • 1.6.3 Market Opportunities
    • 1.6.3.1 Development and Increased Utilization of Biobanks in the Healthcare Segment
    • 1.6.3.2 Shift toward Standardized, Ready-to-Use, and Automation-Compatible Sample Preparation Consumables

2 Workflow

• 2.1 Workflow Summary
• 2.2 Growth-Share Matrix
• 2.3 Sample Isolation/Extraction/Purification
• 2.4 DNA/RNA Clean-Up and Concentration
• 2.5 DNA/RNA Quantification

3 Source Type

• 3.1 Source Type Summary
• 3.2 Growth-Share Matrix
• 3.3 DNA
  • 3.3.1 Cell-Free
    • 3.3.1.1 Blood
    • 3.3.1.2 Serum/Plasma
    • 3.3.1.3 Other Sources
  • 3.3.2 Genomic
    • 3.3.2.1 Blood
    • 3.3.2.2 Body Fluids
    • 3.3.2.3 Buccal
    • 3.3.2.4 Cell/Cultured Cell
    • 3.3.2.5 FFPE
    • 3.3.2.6 Forensic
    • 3.3.2.7 Plant
    • 3.3.2.8 Saliva/Swab
    • 3.3.2.9 Serum/Plasma
    • 3.3.2.10 Tissue
    • 3.3.2.11 Stool, Urine, and Other Samples
  • 3.3.3 Microbe
    • 3.3.3.1 Bacterial
    • 3.3.3.2 Fungus
    • 3.3.3.3 Yeast
    • 3.3.3.4 Other Sources
  • 3.3.4 Plasmids
    • 3.3.4.1 GigaPrep
    • 3.3.4.2 MaxiPrep
    • 3.3.4.3 MegaPrep
    • 3.3.4.4 MidiPrep
    • 3.3.4.5 MiniPrep
  • 3.3.5 Viral
  • 3.3.6 RNA
    • 3.3.6.1 Genomic RNA
      • 3.3.6.1.1 Blood
      • 3.3.6.1.2 Body Fluids
      • 3.3.6.1.3 Cell/Cultured Cell
      • 3.3.6.1.4 FFPE
      • 3.3.6.1.5 Plant
      • 3.3.6.1.6 Saliva/Swab
      • 3.3.6.1.7 Serum/Plasma
      • 3.3.6.1.8 Tissue
      • 3.3.6.1.9 Urine
      • 3.3.6.1.10 Others
    • 3.3.6.2 Microbial RNA
      • 3.3.6.2.1 Bacteria
      • 3.3.6.2.2 Yeast
      • 3.3.6.2.3 Fungus
      • 3.3.6.2.4 Others
    • 3.3.6.3 Viral RNA
    • 3.3.6.4 Cell-Free RNA
      • 3.3.6.4.1 Serum/Plasma
      • 3.3.6.4.2 Others

4 Technology

• 4.1 Technology Summary
• 4.2 Growth-Share Matrix
• 4.3 Silica-Based Technology
• 4.4 Magnetic Particle Technology
• 4.5 Other Technologies

5 Downstream Application

• 5.1 Downstream Applications Summary
• 5.2 Growth-Share Matrix
• 5.3 PCR
• 5.4 qPCR
• 5.5 NGS
• 5.6 Cloning
• 5.7 Microarray
• 5.8 Blotting Techniques
• 5.9 Other Applications

6 End User

• 6.1 End User Summary
• 6.2 Growth-Share Matrix
• 6.3 Academic Research Institutes and Laboratories
• 6.4 Pharmaceutical and Biotechnology Companies
• 6.5 Contract Research Organizations
• 6.6 Applied Testing
• 6.7 Clinical Diagnostic Centers

7 Region

• 7.1 Regional Summary
• 7.2 North America
  • 7.2.1 Regional Overview
  • 7.2.2 Driving Factors for Market Growth
  • 7.2.3 Factors Challenging the Market
  • 7.2.4 By Country
    • 7.2.4.1 U.S.
    • 7.2.4.2 Canada
• 7.3 Europe
  • 7.3.1 Regional Overview
  • 7.3.2 Driving Factors for Market Growth
  • 7.3.3 Factors Challenging the Market
  • 7.3.4 By Country
    • 7.3.4.1 Germany
    • 7.3.4.2 U.K.
    • 7.3.4.3 France
    • 7.3.4.4 Italy
    • 7.3.4.5 Spain
    • 7.3.4.6 Netherlands
    • 7.3.4.7 Poland
    • 7.3.4.8 Portugal
    • 7.3.4.9 Russia
    • 7.3.4.10 Rest-of-Europe
• 7.4 Asia Pacific
  • 7.4.1 Regional Overview
  • 7.4.2 Driving Factors for Market Growth
  • 7.4.3 Factors Challenging the Market
  • 7.4.4 By Country
    • 7.4.4.1 Australia
    • 7.4.4.2 China
    • 7.4.4.3 India
    • 7.4.4.4 Japan
    • 7.4.4.5 Malaysia
    • 7.4.4.6 South Korea
    • 7.4.4.7 Thailand
    • 7.4.4.8 Taiwan
    • 7.4.4.9 Singapore
    • 7.4.4.10 Indonesia
    • 7.4.4.11 Philippines
    • 7.4.4.12 Rest-of-Asia-Pacific
• 7.5 Latin America
  • 7.5.1 Regional Overview
  • 7.5.2 Driving Factors for Market Growth
  • 7.5.3 Factors Challenging the Market
  • 7.5.4 By Country
    • 7.5.4.1 Argentina
    • 7.5.4.2 Brazil
    • 7.5.4.3 Chile
    • 7.5.4.4 Mexico
    • 7.5.4.5 Colombia
    • 7.5.4.6 Rest-of-Latin America
• 7.6 Middle East and Africa
  • 7.6.1 Regional Overview
  • 7.6.2 Driving Factors for Market Growth
  • 7.6.3 Factors Challenging the Market
  • 7.6.4 By Country
    • 7.6.4.1 Saudi Arabia
    • 7.6.4.2 South Africa
    • 7.6.4.3 U.A.E.
    • 7.6.4.4 Rest-of-Middle East and Africa

8 Markets - Competitive Benchmarking & Company Profiles

• 8.1 Product Benchmarking
  • 8.1.1 Product Benchmarking (by Source Type)
    • 8.1.1.1 DNA
    • 8.1.1.2 RNA
• 8.2 Key Strategies and Developments (by Company)
  • 8.2.1 Partnerships, Collaborations, and Business Expansions
  • 8.2.2 New Offerings
• 8.3 Company Share Analysis
  • 8.3.1 DNA
    • 8.3.1.1 Cell-Free DNA
    • 8.3.1.2 Genomic DNA
    • 8.3.1.3 Microbial DNA
    • 8.3.1.4 Plasmid DNA
    • 8.3.1.5 Viral DNA
  • 8.3.2 RNA
    • 8.3.2.1 Cell-Free RNA
    • 8.3.2.2 Genomic RNA
    • 8.3.2.3 Microbial RNA
    • 8.3.2.4 Viral RNA
• 8.4 Company Profiles
  • 8.4.1 Agilent Technologies, Inc.
    • 8.4.1.1 Overview
    • 8.4.1.2 Top Products/Product Portfolio
    • 8.4.1.3 Top Competitors
    • 8.4.1.4 Target Customers
    • 8.4.1.5 Key Personnel
    • 8.4.1.6 Analyst View
  • 8.4.2 AutoGen Inc.
    • 8.4.2.1 Overview
    • 8.4.2.2 Top Products/Product Portfolio
    • 8.4.2.3 Top Competitors
    • 8.4.2.4 Target Customers
    • 8.4.2.5 Key Personnel
    • 8.4.2.6 Analyst View
  • 8.4.3 Bio-Rad Laboratories, Inc.
    • 8.4.3.1 Overview
    • 8.4.3.2 Top Products/Product Portfolio
    • 8.4.3.3 Top Competitors
    • 8.4.3.4 Target Customers
    • 8.4.3.5 Key Personnel
    • 8.4.3.6 Analyst View
  • 8.4.4 F. Hoffmann-La Roche AG
    • 8.4.4.1 Overview
    • 8.4.4.2 Top Products/Product Portfolio
    • 8.4.4.3 Top Competitors
    • 8.4.4.4 Target Customers
    • 8.4.4.5 Key Personnel
    • 8.4.4.6 Analyst View
  • 8.4.5 Merck KGaA
    • 8.4.5.1 Overview
    • 8.4.5.2 Top Products/Product Portfolio
    • 8.4.5.3 Top Competitors
    • 8.4.5.4 Target Customers
    • 8.4.5.5 Key Personnel
    • 8.4.5.6 Analyst View
  • 8.4.6 Macherey-Nagel GmbH & Co KG
    • 8.4.6.1 Overview
    • 8.4.6.2 Top Products/Product Portfolio
    • 8.4.6.3 Top Competitors
    • 8.4.6.4 Target Customers
    • 8.4.6.5 Key Personnel
    • 8.4.6.6 Analyst View
  • 8.4.7 New England Biolabs
    • 8.4.7.1 Overview
    • 8.4.7.2 Top Products/Product Portfolio
    • 8.4.7.3 Top Competitors
    • 8.4.7.4 Target Customers
    • 8.4.7.5 Key Personnel
    • 8.4.7.6 Analyst View
  • 8.4.8 Norgen Biotek Corp
    • 8.4.8.1 Overview
    • 8.4.8.2 Top Products/Product Portfolio
    • 8.4.8.3 Top Competitors
    • 8.4.8.4 Target Customers
    • 8.4.8.5 Key Personnel
    • 8.4.8.6 Analyst View
  • 8.4.9 Omega Bio-tek, Inc.
    • 8.4.9.1 Overview
    • 8.4.9.2 Top Products/Product Portfolio
    • 8.4.9.3 Top Competitors
    • 8.4.9.4 Target Customers
    • 8.4.9.5 Key Personnel
    • 8.4.9.6 Analyst View
  • 8.4.10 QIAGEN N.V.
    • 8.4.10.1 Overview
    • 8.4.10.2 Top Products/Product Portfolio
    • 8.4.10.3 Top Competitors
    • 8.4.10.4 Target Customers
    • 8.4.10.5 Key Personnel
    • 8.4.10.6 Analyst View
  • 8.4.11 Revvity, Inc. (PerkinElmer, Inc.)
    • 8.4.11.1 Overview
    • 8.4.11.2 Top Products/Product Portfolio
    • 8.4.11.3 Top Competitors
    • 8.4.11.4 Target Customers
    • 8.4.11.5 Key Personnel
    • 8.4.11.6 Analyst View
  • 8.4.12 Thermo Fisher Scientific Inc.
    • 8.4.12.1 Overview
    • 8.4.12.2 Top Products/Product Portfolio
    • 8.4.12.3 Top Competitors
    • 8.4.12.4 Target Customers
    • 8.4.12.5 Key Personnel
    • 8.4.12.6 Analyst View
  • 8.4.13 Promega Corporation
    • 8.4.13.1 Overview
    • 8.4.13.2 Top Products/Product Portfolio
    • 8.4.13.3 Top Competitors
    • 8.4.13.4 Target Customers
    • 8.4.13.5 Key Personnel
    • 8.4.13.6 Analyst View
  • 8.4.14 Zymo Research
    • 8.4.14.1 Overview
    • 8.4.14.2 Top Products/Product Portfolio
    • 8.4.14.3 Top Competitors
    • 8.4.14.4 Target Customers
    • 8.4.14.5 Key Personnel
    • 8.4.14.6 Analyst View
  • 8.4.15 LGC Biosearch Technologies
    • 8.4.15.1 Overview
    • 8.4.15.2 Top Products/Product Portfolio
    • 8.4.15.3 Top Competitors
    • 8.4.15.4 Target Customers
    • 8.4.15.5 Key Personnel
    • 8.4.15.6 Analyst View
  • 8.4.16 Danaher Corporation
    • 8.4.16.1 Overview
    • 8.4.16.2 Top Products/Product Portfolio
    • 8.4.16.3 Top Competitors
    • 8.4.16.4 Target Customers
    • 8.4.16.5 Key Personnel
    • 8.4.16.6 Analyst View

9 Research Methodology

• 9.1 Data Sources
  • 9.1.1 Primary Data Sources
  • 9.1.2 Secondary Data Sources
  • 9.1.3 Data Triangulation
• 9.2 Market Estimation and Forecast